SI2003130T1 - Nov piridinski derivat, ki ima aktivnost proti Helicobacter pylori - Google Patents
Nov piridinski derivat, ki ima aktivnost proti Helicobacter pyloriInfo
- Publication number
- SI2003130T1 SI2003130T1 SI200730819T SI200730819T SI2003130T1 SI 2003130 T1 SI2003130 T1 SI 2003130T1 SI 200730819 T SI200730819 T SI 200730819T SI 200730819 T SI200730819 T SI 200730819T SI 2003130 T1 SI2003130 T1 SI 2003130T1
- Authority
- SI
- Slovenia
- Prior art keywords
- gastric
- pyridine derivative
- helicobacter pylori
- novel pyridine
- pyroli
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006066431 | 2006-03-10 | ||
PCT/JP2007/054387 WO2007105551A1 (ja) | 2006-03-10 | 2007-03-07 | 抗ヘリコバクター・ピロリ作用を有する新規ピリジン誘導体 |
EP07715278A EP2003130B1 (en) | 2006-03-10 | 2007-03-07 | Novel pyridine derivative having anti-helicobacter pylori activity |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2003130T1 true SI2003130T1 (sl) | 2012-02-29 |
Family
ID=38509384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200730819T SI2003130T1 (sl) | 2006-03-10 | 2007-03-07 | Nov piridinski derivat, ki ima aktivnost proti Helicobacter pylori |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090143438A1 (sl) |
EP (1) | EP2003130B1 (sl) |
JP (1) | JP5053992B2 (sl) |
KR (1) | KR101348643B1 (sl) |
CN (1) | CN101400670B (sl) |
AT (1) | ATE533757T1 (sl) |
AU (1) | AU2007225935B2 (sl) |
BR (1) | BRPI0708601A2 (sl) |
CA (1) | CA2645467C (sl) |
DK (1) | DK2003130T3 (sl) |
ES (1) | ES2374730T3 (sl) |
HK (1) | HK1122290A1 (sl) |
MX (1) | MX2008011594A (sl) |
PL (1) | PL2003130T3 (sl) |
PT (1) | PT2003130E (sl) |
RU (1) | RU2433126C2 (sl) |
SI (1) | SI2003130T1 (sl) |
WO (1) | WO2007105551A1 (sl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102001024B1 (ko) | 2017-09-29 | 2019-07-17 | 서울프로폴리스 주식회사 | 프로폴리스를 포함하는, 위염 및 헬리코박터 파일로리 억제를 위한 조성물 |
KR102041615B1 (ko) | 2017-09-29 | 2019-11-06 | 서울프로폴리스 주식회사 | 원산지가 다른 프로폴리스 추출물을 혼합 사용하는 프로폴리스의 사용방법 및 프로폴리스를 유효성분으로 하는 건강기능식품용 조성물 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL66340A (en) | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
JPS6150979A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
JPH0674272B2 (ja) * | 1986-11-13 | 1994-09-21 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
JP2694361B2 (ja) | 1989-02-09 | 1997-12-24 | アストラ アクチエボラグ | 抗菌剤 |
JPH0720865B2 (ja) | 1989-02-10 | 1995-03-08 | 武田薬品工業株式会社 | 抗菌剤 |
ES2066120T3 (es) * | 1989-02-10 | 1995-03-01 | Takeda Chemical Industries Ltd | Uso de derivados de bencimidazol como agentes antibacterianos. |
JPH0348680A (ja) | 1989-07-18 | 1991-03-01 | Yoshitomi Pharmaceut Ind Ltd | 抗菌剤 |
JP2798588B2 (ja) | 1992-08-21 | 1998-09-17 | エーザイ株式会社 | 抗菌剤 |
ATE192932T1 (de) * | 1993-09-09 | 2000-06-15 | Takeda Chemical Industries Ltd | Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff |
JPH07126189A (ja) * | 1993-09-09 | 1995-05-16 | Takeda Chem Ind Ltd | 抗潰瘍併用療法用製剤 |
HUT76639A (en) * | 1994-07-20 | 1997-10-28 | Byk Gulden Lomberg Chem Fab | Pyridyl-thio-compounds, process for producing them and their use |
ES2214802T3 (es) | 1994-08-30 | 2004-09-16 | Nagase Chemtex Corporation | Intermedios para la preparacion de derivados de esteres de acido guanidinometilciclohexanocarboxilico. |
EP0870500B1 (en) | 1995-12-22 | 2008-02-20 | Nagase ChemteX Corporation | Anti-helicobacter pylori agent |
CN1205632A (zh) * | 1995-12-22 | 1999-01-20 | 帝国化学产业株式会社 | 抗幽门螺杆菌剂 |
ES2171116B1 (es) * | 2000-04-14 | 2003-08-01 | Esteve Quimica Sa | Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol. |
JP4490765B2 (ja) | 2004-08-24 | 2010-06-30 | 株式会社東芝 | 熱−電気直接変換装置 |
-
2007
- 2007-03-07 RU RU2008140164/04A patent/RU2433126C2/ru not_active IP Right Cessation
- 2007-03-07 PL PL07715278T patent/PL2003130T3/pl unknown
- 2007-03-07 KR KR1020087020176A patent/KR101348643B1/ko not_active IP Right Cessation
- 2007-03-07 CA CA2645467A patent/CA2645467C/en not_active Expired - Fee Related
- 2007-03-07 PT PT07715278T patent/PT2003130E/pt unknown
- 2007-03-07 US US12/225,007 patent/US20090143438A1/en not_active Abandoned
- 2007-03-07 AT AT07715278T patent/ATE533757T1/de active
- 2007-03-07 MX MX2008011594A patent/MX2008011594A/es active IP Right Grant
- 2007-03-07 AU AU2007225935A patent/AU2007225935B2/en not_active Ceased
- 2007-03-07 JP JP2008505075A patent/JP5053992B2/ja not_active Expired - Fee Related
- 2007-03-07 BR BRPI0708601-6A patent/BRPI0708601A2/pt not_active IP Right Cessation
- 2007-03-07 CN CN2007800086759A patent/CN101400670B/zh not_active Expired - Fee Related
- 2007-03-07 ES ES07715278T patent/ES2374730T3/es active Active
- 2007-03-07 DK DK07715278.3T patent/DK2003130T3/da active
- 2007-03-07 SI SI200730819T patent/SI2003130T1/sl unknown
- 2007-03-07 WO PCT/JP2007/054387 patent/WO2007105551A1/ja active Search and Examination
- 2007-03-07 EP EP07715278A patent/EP2003130B1/en not_active Not-in-force
-
2009
- 2009-01-19 HK HK09100493.3A patent/HK1122290A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2645467A1 (en) | 2007-09-20 |
MX2008011594A (es) | 2008-09-22 |
EP2003130A2 (en) | 2008-12-17 |
RU2008140164A (ru) | 2010-04-20 |
WO2007105551A1 (ja) | 2007-09-20 |
KR101348643B1 (ko) | 2014-01-08 |
EP2003130A4 (en) | 2010-12-22 |
HK1122290A1 (en) | 2009-05-15 |
EP2003130B1 (en) | 2011-11-16 |
CN101400670A (zh) | 2009-04-01 |
ATE533757T1 (de) | 2011-12-15 |
AU2007225935B2 (en) | 2011-12-22 |
RU2433126C2 (ru) | 2011-11-10 |
US20090143438A1 (en) | 2009-06-04 |
BRPI0708601A2 (pt) | 2011-06-07 |
AU2007225935A1 (en) | 2007-09-20 |
CN101400670B (zh) | 2012-10-10 |
DK2003130T3 (da) | 2011-12-12 |
ES2374730T3 (es) | 2012-02-21 |
JP5053992B2 (ja) | 2012-10-24 |
JPWO2007105551A1 (ja) | 2009-07-30 |
EP2003130A9 (en) | 2009-04-15 |
PT2003130E (pt) | 2012-01-10 |
PL2003130T3 (pl) | 2012-04-30 |
CA2645467C (en) | 2012-04-24 |
KR20090005292A (ko) | 2009-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009004096A (es) | Metabolitos de talarozol. | |
WO2007009656A3 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
WO2007095174A3 (en) | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions | |
WO2008019967A3 (en) | Phenyl, pyridine and quinoline derivatives | |
TW200728307A (en) | Novel spirochromanone derivatives | |
MY137039A (en) | Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof | |
LU91761I2 (fr) | Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®) | |
WO2006113552A8 (en) | Cyanoarylamines | |
TW200716650A (en) | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency | |
TW200716527A (en) | Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives | |
CA2671949A1 (en) | Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion | |
AU3605201A (en) | Urease inhibitors | |
CA2513555A1 (en) | Process for the preparation of pyridylsulfinylbenzimidazoles | |
HK1122290A1 (en) | Novel pyridine derivative having anti-helicobacter pylori activity | |
BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
WO2003027098A1 (fr) | Compose de benzymidazole, procede de production et d'utilisation de celui-ci | |
TW200730177A (en) | 4 anilino-3-quinolinecarbonitriles for the treatment of cancer | |
JP2006524208A5 (sl) | ||
WO2008016661A3 (en) | Morpholino compounds for treating inflammatory and demyelinating diseases and cancers | |
AU2010235726B2 (en) | Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-Helicobacter pylori action | |
BR0211127A (pt) | Utilização de um composto | |
MX2008002753A (es) | Derivados de piridazinona utilizados para el tratamiento de dolor. | |
UA86396C2 (ru) | Производные тиофена как ингибиторы снк 1 | |
UA100002C2 (en) | Normal;heading 1;heading 2;heading 3;PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |